| Literature DB >> 30930169 |
Hisayuki Amano1, Arindam Chaudhury2, Cristian Rodriguez-Aguayo3, Lan Lu4, Viktor Akhanov5, Andre Catic5, Yury V Popov6, Eric Verdin7, Hannah Johnson8, Fabio Stossi8, David A Sinclair9, Eiko Nakamaru-Ogiso10, Gabriel Lopez-Berestein3, Jeffrey T Chang11, Joel R Neilson2, Alan Meeker12, Milton Finegold13, Joseph A Baur14, Ergun Sahin15.
Abstract
Telomere shortening is associated with stem cell decline, fibrotic disorders, and premature aging through mechanisms that are incompletely understood. Here, we show that telomere shortening in livers of telomerase knockout mice leads to a p53-dependent repression of all seven sirtuins. P53 regulates non-mitochondrial sirtuins (Sirt1, 2, 6, and 7) post-transcriptionally through microRNAs (miR-34a, 26a, and 145), while the mitochondrial sirtuins (Sirt3, 4, and 5) are regulated in a peroxisome proliferator-activated receptor gamma co-activator 1 alpha-/beta-dependent manner at the transcriptional level. Administration of the NAD(+) precursor nicotinamide mononucleotide maintains telomere length, dampens the DNA damage response and p53, improves mitochondrial function, and, functionally, rescues liver fibrosis in a partially Sirt1-dependent manner. These studies establish sirtuins as downstream targets of dysfunctional telomeres and suggest that increasing Sirt1 activity alone or in combination with other sirtuins stabilizes telomeres and mitigates telomere-dependent disorders.Entities:
Keywords: liver disease; metabolism; p53; sirtuins; telomeres
Year: 2019 PMID: 30930169 PMCID: PMC6657508 DOI: 10.1016/j.cmet.2019.03.001
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287